05:20 PM EST, 02/27/2025 (MT Newswires) -- Neil Kumar, Director, Chief Executive Officer, on February 25, 2025, sold 75,000 shares in Bridgebio Pharma ( BBIO ) for $2,517,971. Following the Form 4 filing with the SEC, Kumar has control over a total of 6,230,851 common shares of the company, with 211,718 shares held directly and 6,019,133 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1743881/000095017025029228/xslF345X05/ownership.xml